Anthony Cnudde, Camille Allely, Natacha Biset, Pierre Champy, Nathalie Fouilhé, Fanny Huret, Sibi Lawson, Aline Mercan, Doris Pascale Noukela Noumi, Serge Michalet, Andrea Montis, Stephanie Pochet, Audrey Schils, Cecilia Tangeten, Michel Tod, Pierre Van Antwerpen, Audrey Vervacke, Florence Souard
{"title":"BABINE: An original and user-friendly scale for the simple and quick management of herb-drug interactions in clinical practice.","authors":"Anthony Cnudde, Camille Allely, Natacha Biset, Pierre Champy, Nathalie Fouilhé, Fanny Huret, Sibi Lawson, Aline Mercan, Doris Pascale Noukela Noumi, Serge Michalet, Andrea Montis, Stephanie Pochet, Audrey Schils, Cecilia Tangeten, Michel Tod, Pierre Van Antwerpen, Audrey Vervacke, Florence Souard","doi":"10.1186/s12906-024-04706-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>While more and more people tend to use herbal products thinking they are safer than conventional western medicine, the reality is other. If natural products are bio-active and possess potential therapeutic activities, then the benefit/risk balance should be considered like any other health product. Some herbs are known to have the potential to interact with patient's treatment and to cause adverse drug reactions. While these are scarce, they are potentially harmful, and can lead to major sequels and even death in some cases. Despite these known facts, little guidelines about how to evaluate the risk of interaction and to handle them exist in literature. Notably, few scales allowing to assess the risk of a specific combination of herbs and drugs exist.</p><p><strong>Method: </strong>We propose a new scoring method BABINE (Boosting Analysis of Bibliography for herb- drug INteraction Evaluation) and discuss a scale to evaluate this risk based on iterative rounds of experts' discussion.</p><p><strong>Results: </strong>After 6 rounds of case reports/clinical studies evaluation, we analyzed and synthesized criteria identified as important by the experts and developed a corresponding evaluation scale.</p><p><strong>Conclusion: </strong>Even if our scale greatly simplifies pharmacological events, we believe it provides a robust and transparent way to rapidly assess the risk of adverse event.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":"24 1","pages":"414"},"PeriodicalIF":3.4000,"publicationDate":"2024-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11654206/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Complementary Medicine and Therapies","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12906-024-04706-9","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
Background: While more and more people tend to use herbal products thinking they are safer than conventional western medicine, the reality is other. If natural products are bio-active and possess potential therapeutic activities, then the benefit/risk balance should be considered like any other health product. Some herbs are known to have the potential to interact with patient's treatment and to cause adverse drug reactions. While these are scarce, they are potentially harmful, and can lead to major sequels and even death in some cases. Despite these known facts, little guidelines about how to evaluate the risk of interaction and to handle them exist in literature. Notably, few scales allowing to assess the risk of a specific combination of herbs and drugs exist.
Method: We propose a new scoring method BABINE (Boosting Analysis of Bibliography for herb- drug INteraction Evaluation) and discuss a scale to evaluate this risk based on iterative rounds of experts' discussion.
Results: After 6 rounds of case reports/clinical studies evaluation, we analyzed and synthesized criteria identified as important by the experts and developed a corresponding evaluation scale.
Conclusion: Even if our scale greatly simplifies pharmacological events, we believe it provides a robust and transparent way to rapidly assess the risk of adverse event.
背景:虽然越来越多的人倾向于使用草药产品,认为它们比传统的西医更安全,但事实并非如此。如果天然产品具有生物活性并具有潜在的治疗活性,那么应该像其他任何健康产品一样考虑利益/风险平衡。一些草药已知有可能与病人的治疗相互作用并引起药物不良反应。虽然这些药物很稀少,但它们具有潜在的危害,在某些情况下可能导致严重的后遗症,甚至死亡。尽管有这些已知的事实,但在文献中几乎没有关于如何评估互动风险和处理它们的指导方针。值得注意的是,很少有量表允许评估草药和药物的特定组合的风险。方法:提出了一种新的评分方法BABINE (Boosting Analysis of Bibliography for herb- drug INteraction Evaluation),并在专家反复讨论的基础上讨论了一种评估这种风险的量表。结果:经过6轮病例报告/临床研究评价,我们对专家认为重要的标准进行分析综合,制定出相应的评价量表。结论:即使我们的量表极大地简化了药理学事件,我们相信它提供了一种可靠和透明的方法来快速评估不良事件的风险。